Sharon Stein, MD
Specialty: Colon and Rectal Surgery
- Program Director, Colorectal Surgery, UH Cleveland Medical Center
- Director, UH Rises, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
Sharon L. Stein, MD, FACS, FASCRS, is a colorectal surgeon at University Hospitals Cleveland Medical Center and Associate Professor, Surgery at Case Western Reserve University School of Medicine. She is the Director of UH RISES: Research in Surgical Outcomes and Effectiveness Center. She was recently appointed at the Murdough Master Clinician in Colorectal Surgery for outstanding contributions to her patients and university. She is the president of the Association of Women Surgeons.
Dr. Stein was the first women to receive an Honorary Fellowship from the Association of Surgeons of Great Britain and Ireland. As an academician, Dr. Stein has published over 100 articles, abstracts and chapters on a variety of topics from minimally invasive surgery to diversity in surgery. Her programmatic experiences also inform her academic pursuits; she has written about the salary gap in surgery, starting salaries for colon and rectal surgeons, and pregnancy leave internationally, in addition to traditional topics of minimally invasive surgery, rectal cancer and enhanced recovery protocols. In recognition of her contributions to scholarship, she has been invited to serve as a reviewer for a number of prestigious journals and to write several book chapters. She has been invited to deliver CME lectures and contribute to scientific publications both nationally and internationally. She was recently chosen by the Society of University Surgeons (SUS) along with the Society of Black Academic Surgeons (SBAS), the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), and the Eastern Association for the Surgery of Trauma (EAST) to participate in 2020 Promising Leaders Program.
- Anal Cancer
- Colitis Ulcerosa
- Colon and Rectal Cancer
- Colon Polyps
- Colovaginal Fistula
- Colovesical Fistula
- Crohn's Disease
- Diverticular Disease
- Enterocutaneous Fistula
- Fecal Incontinence
- Inflammatory Bowel Disease (IBD)
- Laparoscopic Colon and Rectal Surgery
- Minimally Invasive Colorectal Surgery
- Rectal Cancer
- Rectovaginal Fistula
- Robotic Colon and Rectal Surgery
- Transanal Total Mesorectal Surgery
- Ulcerative Colitis
Certifications & Memberships
- Colon and Rectal Surgery - American Board of Colon and Rectal Surgery
- Surgery - American Board of Surgery
Fellowship | Colon and Rectal Surgery
Colon and Rectal Surgery - New York-Presbyterian/Columbia University Medical Center (2006 - 2007)
Residency | General Surgery
General Surgery - Massachusetts General Hospital (2001 - 2006)
University Of Colorado School Of Medicine (2001)
University Of Michigan (1990)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Sharon Stein did not disclose any Outside Relationships with Industry.